Page last updated: 2024-08-26

bosentan anhydrous and Atherosclerosis

bosentan anhydrous has been researched along with Atherosclerosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, G; Xu, X; Zhao, Z1
Acin, F; Bleda, S; De Haro, J; Gonzalez-Hidalgo, C; Michel, I1
Bouras, G; Cleman, MW; Deftereos, S; Giannopoulos, G; Kaoukis, A; Panagopoulou, V; Papoutsidakis, N; Raisakis, K; Stefanadis, C1
Courtman, DW; Rampersad, SN; Stewart, DJ; Suen, RS1
Davenport, AP; Maguire, JJ1
Delgado, DH; Jackman, J; Ramzy, D; Rao, V; Ross, HJ; Sheshgiri, R; Tumiati, LC; Xu, N1

Reviews

2 review(s) available for bosentan anhydrous and Atherosclerosis

ArticleYear
The role of endothelin system in cardiovascular disease and the potential therapeutic perspectives of its inhibition.
    Current topics in medicinal chemistry, 2013, Volume: 13, Issue:2

    Topics: Animals; Atherosclerosis; Atrial Fibrillation; Bosentan; Cardiovascular Diseases; Coronary Artery Disease; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Humans; Hypertension, Pulmonary; Phenylpropionates; Predictive Value of Tests; Pyridazines; Receptors, Endothelin; Sulfonamides

2013
Endothelin.
    Handbook of experimental pharmacology, 2006, Issue:176 Pt 1

    Topics: Amino Acid Sequence; Animals; Antihypertensive Agents; Aspartic Acid Endopeptidases; Atherosclerosis; Binding Sites; Bosentan; Endothelin-Converting Enzymes; Endothelins; Endothelium, Vascular; Humans; Hypertension; Hypertension, Pulmonary; Metalloendopeptidases; Molecular Sequence Data; Muscle, Smooth, Vascular; Receptors, Endothelin; Signal Transduction; Sulfonamides; Vasoconstrictor Agents; Viper Venoms

2006

Trials

1 trial(s) available for bosentan anhydrous and Atherosclerosis

ArticleYear
Long-Term Effects of Bosentan on Cardiovascular Events in Hispanic Patients with Intermittent Claudication: Four-Year Follow-up of the CLAU Trial : The CLAU Randomized Trial Long-Term Outcome.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2019, Volume: 19, Issue:2

    Topics: Antihypertensive Agents; Atherosclerosis; Bosentan; Follow-Up Studies; Hispanic or Latino; Humans; Intermittent Claudication; Male; Middle Aged; Peripheral Arterial Disease; Treatment Outcome

2019

Other Studies

3 other study(ies) available for bosentan anhydrous and Atherosclerosis

ArticleYear
The Protective Effect of Bosentan against Atherosclerosis in Apolipoprotein E-Deficient Mice Is Mediated by miRNA-21.
    BioMed research international, 2019, Volume: 2019

    Topics: Animals; Aorta, Thoracic; Apolipoproteins E; Apoptosis Regulatory Proteins; Atherosclerosis; bcl-2-Associated X Protein; Body Weight; Bosentan; Caspase 3; Diet, High-Fat; Lipids; Mice; Mice, Inbred C57BL; MicroRNAs; Protective Agents; RNA-Binding Proteins; RNA, Messenger

2019
Differential roles of endothelin-1 in angiotensin II-induced atherosclerosis and aortic aneurysms in apolipoprotein E-null mice.
    The American journal of pathology, 2011, Volume: 179, Issue:3

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Aortic Aneurysm; Apolipoproteins E; Atherosclerosis; Biomechanical Phenomena; Bosentan; Cardiovascular Agents; Cell Adhesion; Collagen; Down-Regulation; Endothelin-1; Integrin beta1; Interferon-gamma; Mice; Mice, Knockout; Stress, Physiological; Sulfonamides; Vasoconstrictor Agents

2011
Endothelin-1 accentuates the proatherosclerotic effects associated with C-reactive protein.
    The Journal of thoracic and cardiovascular surgery, 2007, Volume: 133, Issue:5

    Topics: Alkaloids; Atherosclerosis; Benzophenanthridines; Bosentan; C-Reactive Protein; Cells, Cultured; Cytokines; Endothelin-1; Endothelium, Vascular; Homeostasis; Humans; Naphthalenes; Nitric Oxide; Nitric Oxide Synthase Type III; Protein Kinase C; Saphenous Vein; Sulfonamides

2007